Valeant Pharma (NYSE: VRX) announced that yesterday it entered into an amended and restated "stalking horse" asset purchase agreement to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE